Global Co-Processed Excipients Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032
Description
According to our (Global Info Research) latest study, the global Co-Processed Excipients market size was valued at US$ 2431 million in 2025 and is forecast to a readjusted size of US$ 3297 million by 2032 with a CAGR of 4.5% during review period.
Co-processed excipients are combinations of two or more individual excipients that are physically modified without chemical alteration to enhance their functionalities, such as flowability, compressibility, or dissolution properties. These excipients are engineered to achieve synergies in performance compared to their individual components, making them particularly valuable in pharmaceutical formulations, especially for direct compression and tablet manufacturing.
Characteristics of Co-Processed Excipients:
Physical but Not Chemical Modification: No chemical bonds are formed; their advantages arise from optimized physical properties.
Improved Functionality: Enhanced performance metrics like compressibility, flowability, and reduced tablet capping.
Reduced Formulation Complexity: Combining multiple functionalities into a single excipient simplifies production and quality control.
Cost Efficiency: They can reduce the total number of excipients and minimize manufacturing steps.
In 2024, global Co-Processed Excipients production reached approximately 336.4 K MT, with an average global market price of around US$ 6,782 per MT. The global single-line production capacity ranges from 25 to 40 K MT per year. The industry's gross profit margin is approximately 25%-35%.
One of the most significant trends shaping the co-processed excipients industry is the move from traditional excipients to functionality-based excipient systems. Historically, excipients were viewed as inert substances that merely served as fillers, binders, or disintegrants. However, modern drug development increasingly recognizes excipients as key formulation enablers. Co-processed excipients exemplify this evolution by delivering multifunctional performance—enhancing flow properties, tablet hardness, disintegration, and content uniformity simultaneously. As new active pharmaceutical ingredients (APIs) become more potent, sensitive, and poorly compressible, formulators are turning to co-processed excipients to overcome these challenges without resorting to complex granulation processes. This functional transformation aligns with the pharmaceutical industry’s broader shift toward efficiency, robustness, and reduced processing steps.
The expansion of direct compression (DC) technology is another major driver of co-processed excipient development. Direct compression simplifies tablet manufacturing by eliminating wet granulation and drying steps, significantly reducing time, cost, and energy consumption. However, DC requires excipients with exceptional flowability and compressibility—properties not always achievable through traditional materials. Co-processed excipients like MCC-lactose or MCC-mannitol blends are specifically engineered for this purpose, providing uniform particle size, reduced segregation, and consistent die filling. The increasing industrial adoption of DC, particularly in generic drug production, is accelerating the demand for co-processed excipients that can perform well under high-speed tableting conditions and maintain tablet uniformity even with low-dose or moisture-sensitive APIs.
Another major trend is the increasing use of co-processed excipients in orally disintegrating tablets (ODTs) and other patient-centric dosage forms. Modern consumers, especially pediatric and geriatric populations, prefer formulations that are easy to swallow and pleasant in taste. Co-processed excipients containing mannitol, sorbitol, or other sugar alcohols are commonly employed to provide rapid disintegration, good mouthfeel, and taste-masking capabilities. Their ability to balance mechanical strength and fast disintegration makes them ideal for ODT manufacturing, which demands both robustness during packaging and rapid dissolution upon administration. The trend toward self-administration, improved patient compliance, and personalized dosing formats further supports the integration of co-processed excipients into new drug delivery systems, including chewable tablets, sublinguals, and dispersible powders.
Regulatory acceptance is another important trend in the co-processed excipient industry. While co-processed excipients are composed of existing, pharmacopeia-listed materials, their combination creates a new physical entity that requires characterization and justification for regulatory submission. Regulatory bodies such as the U.S. Food and Drug Administration (FDA) and European Medicines Agency (EMA) have gradually acknowledged co-processed excipients as legitimate formulation components, provided their safety, performance, and stability are well-documented. The increasing publication of monographs and quality standards for co-processed excipients in compendia such as the European Pharmacopoeia (Ph. Eur.) and United States Pharmacopeia (USP) is a clear sign of regulatory progress. This recognition helps reduce barriers to market entry and encourages further innovation in excipient development.
Co-processed excipients industry has a low level of market concentration, for top 5 companies only occupying less than 30% of the global market. Global important companies in co-processed excipients includes Roquette, JSR Pharma and Shin-Etsu.
This report is a detailed and comprehensive analysis for global Co-Processed Excipients market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Co-Processed Excipients market size and forecasts, in consumption value ($ Million), sales quantity (Kilotons), and average selling prices (US$/Ton), 2021-2032
Global Co-Processed Excipients market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Kilotons), and average selling prices (US$/Ton), 2021-2032
Global Co-Processed Excipients market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Kilotons), and average selling prices (US$/Ton), 2021-2032
Global Co-Processed Excipients market shares of main players, shipments in revenue ($ Million), sales quantity (Kilotons), and ASP (US$/Ton), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Co-Processed Excipients
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Co-Processed Excipients market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Meggle, Roquette, BASF, JRS Pharma, ABF Ingredients, Colorcon, Daicel Corporation, Shin-Etsu, IFF (DuPont), Fuji, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Co-Processed Excipients market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Granulation
Spray Drying
Hot Melt Extrusion
Solvent Evaporation
Others
Market segment by Dosage Form
Direct Compression Tablets
Orally Disintegrating Tablets (ODTs)
Effervescent Tablets or Powders
Capsule Fillers and Pellets
Others
Market segment by Composition
Cellulose-Based Systems
Sugar-Based Systems
Inorganic-Organic Blends
Polyol-Based Systems
Others
Market segment by Physical Form
Fine Powder Form
Granular Form
Spherical or Spray-Dried Particles
High-Density or Low-Density Grades
Others
Market segment by Application
Pharmaceuticals
Nutraceuticals
Major players covered
Meggle
Roquette
BASF
JRS Pharma
ABF Ingredients
Colorcon
Daicel Corporation
Shin-Etsu
IFF (DuPont)
Fuji
Topchain
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Co-Processed Excipients product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Co-Processed Excipients, with price, sales quantity, revenue, and global market share of Co-Processed Excipients from 2021 to 2026.
Chapter 3, the Co-Processed Excipients competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Co-Processed Excipients breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Co-Processed Excipients market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Co-Processed Excipients.
Chapter 14 and 15, to describe Co-Processed Excipients sales channel, distributors, customers, research findings and conclusion.
Co-processed excipients are combinations of two or more individual excipients that are physically modified without chemical alteration to enhance their functionalities, such as flowability, compressibility, or dissolution properties. These excipients are engineered to achieve synergies in performance compared to their individual components, making them particularly valuable in pharmaceutical formulations, especially for direct compression and tablet manufacturing.
Characteristics of Co-Processed Excipients:
Physical but Not Chemical Modification: No chemical bonds are formed; their advantages arise from optimized physical properties.
Improved Functionality: Enhanced performance metrics like compressibility, flowability, and reduced tablet capping.
Reduced Formulation Complexity: Combining multiple functionalities into a single excipient simplifies production and quality control.
Cost Efficiency: They can reduce the total number of excipients and minimize manufacturing steps.
In 2024, global Co-Processed Excipients production reached approximately 336.4 K MT, with an average global market price of around US$ 6,782 per MT. The global single-line production capacity ranges from 25 to 40 K MT per year. The industry's gross profit margin is approximately 25%-35%.
One of the most significant trends shaping the co-processed excipients industry is the move from traditional excipients to functionality-based excipient systems. Historically, excipients were viewed as inert substances that merely served as fillers, binders, or disintegrants. However, modern drug development increasingly recognizes excipients as key formulation enablers. Co-processed excipients exemplify this evolution by delivering multifunctional performance—enhancing flow properties, tablet hardness, disintegration, and content uniformity simultaneously. As new active pharmaceutical ingredients (APIs) become more potent, sensitive, and poorly compressible, formulators are turning to co-processed excipients to overcome these challenges without resorting to complex granulation processes. This functional transformation aligns with the pharmaceutical industry’s broader shift toward efficiency, robustness, and reduced processing steps.
The expansion of direct compression (DC) technology is another major driver of co-processed excipient development. Direct compression simplifies tablet manufacturing by eliminating wet granulation and drying steps, significantly reducing time, cost, and energy consumption. However, DC requires excipients with exceptional flowability and compressibility—properties not always achievable through traditional materials. Co-processed excipients like MCC-lactose or MCC-mannitol blends are specifically engineered for this purpose, providing uniform particle size, reduced segregation, and consistent die filling. The increasing industrial adoption of DC, particularly in generic drug production, is accelerating the demand for co-processed excipients that can perform well under high-speed tableting conditions and maintain tablet uniformity even with low-dose or moisture-sensitive APIs.
Another major trend is the increasing use of co-processed excipients in orally disintegrating tablets (ODTs) and other patient-centric dosage forms. Modern consumers, especially pediatric and geriatric populations, prefer formulations that are easy to swallow and pleasant in taste. Co-processed excipients containing mannitol, sorbitol, or other sugar alcohols are commonly employed to provide rapid disintegration, good mouthfeel, and taste-masking capabilities. Their ability to balance mechanical strength and fast disintegration makes them ideal for ODT manufacturing, which demands both robustness during packaging and rapid dissolution upon administration. The trend toward self-administration, improved patient compliance, and personalized dosing formats further supports the integration of co-processed excipients into new drug delivery systems, including chewable tablets, sublinguals, and dispersible powders.
Regulatory acceptance is another important trend in the co-processed excipient industry. While co-processed excipients are composed of existing, pharmacopeia-listed materials, their combination creates a new physical entity that requires characterization and justification for regulatory submission. Regulatory bodies such as the U.S. Food and Drug Administration (FDA) and European Medicines Agency (EMA) have gradually acknowledged co-processed excipients as legitimate formulation components, provided their safety, performance, and stability are well-documented. The increasing publication of monographs and quality standards for co-processed excipients in compendia such as the European Pharmacopoeia (Ph. Eur.) and United States Pharmacopeia (USP) is a clear sign of regulatory progress. This recognition helps reduce barriers to market entry and encourages further innovation in excipient development.
Co-processed excipients industry has a low level of market concentration, for top 5 companies only occupying less than 30% of the global market. Global important companies in co-processed excipients includes Roquette, JSR Pharma and Shin-Etsu.
This report is a detailed and comprehensive analysis for global Co-Processed Excipients market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Co-Processed Excipients market size and forecasts, in consumption value ($ Million), sales quantity (Kilotons), and average selling prices (US$/Ton), 2021-2032
Global Co-Processed Excipients market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Kilotons), and average selling prices (US$/Ton), 2021-2032
Global Co-Processed Excipients market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Kilotons), and average selling prices (US$/Ton), 2021-2032
Global Co-Processed Excipients market shares of main players, shipments in revenue ($ Million), sales quantity (Kilotons), and ASP (US$/Ton), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Co-Processed Excipients
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Co-Processed Excipients market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Meggle, Roquette, BASF, JRS Pharma, ABF Ingredients, Colorcon, Daicel Corporation, Shin-Etsu, IFF (DuPont), Fuji, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Co-Processed Excipients market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Granulation
Spray Drying
Hot Melt Extrusion
Solvent Evaporation
Others
Market segment by Dosage Form
Direct Compression Tablets
Orally Disintegrating Tablets (ODTs)
Effervescent Tablets or Powders
Capsule Fillers and Pellets
Others
Market segment by Composition
Cellulose-Based Systems
Sugar-Based Systems
Inorganic-Organic Blends
Polyol-Based Systems
Others
Market segment by Physical Form
Fine Powder Form
Granular Form
Spherical or Spray-Dried Particles
High-Density or Low-Density Grades
Others
Market segment by Application
Pharmaceuticals
Nutraceuticals
Major players covered
Meggle
Roquette
BASF
JRS Pharma
ABF Ingredients
Colorcon
Daicel Corporation
Shin-Etsu
IFF (DuPont)
Fuji
Topchain
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Co-Processed Excipients product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Co-Processed Excipients, with price, sales quantity, revenue, and global market share of Co-Processed Excipients from 2021 to 2026.
Chapter 3, the Co-Processed Excipients competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Co-Processed Excipients breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Co-Processed Excipients market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Co-Processed Excipients.
Chapter 14 and 15, to describe Co-Processed Excipients sales channel, distributors, customers, research findings and conclusion.
Table of Contents
110 Pages
- 1 Market Overview
- 2 Manufacturers Profiles
- 3 Competitive Environment: Co-Processed Excipients by Manufacturer
- 4 Consumption Analysis by Region
- 5 Market Segment by Type
- 6 Market Segment by Application
- 7 North America
- 8 Europe
- 9 Asia-Pacific
- 10 South America
- 11 Middle East & Africa
- 12 Market Dynamics
- 13 Raw Material and Industry Chain
- 14 Shipments by Distribution Channel
- 15 Research Findings and Conclusion
- 16 Appendix
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
